Rchr
J-GLOBAL ID:201801013713509933
Update date: Aug. 26, 2022
Nishino Satoshi
Nishino Satoshi
Contact this researcher
You can send email directly to the researcher.
Papers (14):
Asuka Mogi, Ryo Yomoda, Syunya Kimura, Chisato Tsushima, Jun Takouda, Miho Sawauchi, Tomoko Maekawa, Hidenobu Ohta, Satoshi Nishino, Masatake Kurita, et al. Entrainment of the Circadian Clock in Neural Stem Cells by Epidermal Growth Factor is Closely Associated with ERK1/2-mediated Induction of Multiple Clock-related Genes. Neuroscience. 2018. 379. 45-66
Atsuko Kawai, Masatake Kurita, Satoshi Nishino, Eishin Hirata, Tadahiro Sato, Yoshiro Okubo. Need for medication to complement catecholamines in smoking cessation of hardcore smokers. Neuropsychiatric Disease and Treatment. 2017. 13. 2419-2424
Masatake Kurita, Takahiro Moriya, Satoshi Nishino, Eishin Hirata, Noriyasu Hirasawa, Yoshiro Okubo, Tadahiro Sato. Non-24-hour sleep-wake syndrome improved by low-dose valproic acid: A case report. Neuropsychiatric Disease and Treatment. 2016. 12. 3199-3203
Kenji Takeyoshi, Masatake Kurita, Satoshi Nishino, Mika Teranishi, Yukio Numata, Tadahiro Sato, Yoshiro Okubo. Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function. Neuropsychiatric Disease and Treatment. 2016. 12. 641-649
Masatake Kurita, Satoshi Nishino, Yukio Numata, Yoshiro Okubo, Tadahiro Sato. The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: Two long-term naturalistic case reports. Neuropsychiatric Disease and Treatment. 2015. 11. 353-358
more...
MISC (71):
川合厚子, 川合厚子, 栗田征武, 栗田征武, 栗田征武, 西野敏, 西野敏, 平田詠信, 佐藤忠宏, 大久保善朗. ハードコアスモーカーの禁煙治療にカテコールアミンを補完する薬物療法の必要性. 日本禁煙学会学術総会プログラム・抄録集. 2017. 11th. 198
栗田征武, 栗田征武, 栗田征武, 西野敏, 西野敏. 双極性障害薬物療法のState of the Art I 気分安定薬としての新しい抗てんかん薬(Lamotrigineなど). 精神科治療学. 2017. 32. 9. 1163-1169
栗田 征武, 西野 敏. New antiepileptic drugs which act as a mood stabilizer. 精神科治療学. 2017. 32. 9. 1163-1169
栗田征武, 栗田征武, 栗田征武, 西野敏, 西野敏, 加藤舞子, 沼田由紀夫, 佐藤忠宏. うつ病の治療で血漿BDNFは寛解群では増加するが非反応群では減少する. 心身医学. 2016. 56. 11. 1147-1148-1148
栗田征武, 栗田征武, 栗田征武, 西野敏, 西野敏. 新しく導入が期待されるうつ病治療薬のエビデンス うつ病治療における気分安定薬の位置づけ. 臨床精神薬理. 2016. 19. 7. 957-965-965
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM